EdgarLookup

Synergy CHC Corp. — Insider Transactions

Form 4 filings by directors, officers, and 10%+ shareholders

SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.

Overview All Filings Annual Quarterly Insiders
Insider Title Type Shares Price Value Owns After Date
Ross Jack CEO and Chairman Purchase 2,600 $2.69 $6,994 399,407 Jul 2, 2025
Ross Jack CEO and Chairman Purchase 9,400 $1.77 $16,638 378,307 Jun 10, 2025
Ross Jack CEO and Chairman Purchase 500 $2.14 $1,070 366,507 Apr 11, 2025
Ross Jack CEO and Chairman Purchase 500 $2.00 $1,000 360,907 Apr 8, 2025
Ross Jack CEO and Chairman Purchase 1,600 $3.80 $6,080 341,227 Feb 6, 2025
Ross Jack CEO and Chairman Purchase 50 $5.46 $273 328,417 Nov 27, 2024
Ross Jack CEO and Chairman Purchase 300,000 $9.00 $2,700,000 300,000 Oct 24, 2024
Ross Jack President, CEO and CFO Purchase 3,000,000 $0.15 $450,000 4,625,034 May 19, 2020
Ross Jack President and CEO Purchase 228,572 $0.04 $9,143 1,853,606 Jan 21, 2020
Ross Jack President and CEO Purchase 1,225,034 $0.55 $673,769 1,625,034 Dec 10, 2018
Ross Jack President and CEO Purchase 1,225,034 $0.55 $673,769 1,225,034 Dec 10, 2018
Knight Therapeutics (Barbados) Inc. Other 7,500,000 17,645,812 Dec 22, 2016
Gowan Private Equity Inc. Purchase 7,936,850 $0.03 $238,106 44,053,100 Dec 4, 2015
Ross Jack President & CEO Purchase 7,936,850 $0.03 $238,106 44,053,100 Dec 4, 2015
Knight Therapeutics (Barbados) Inc. Other 5,550,625 10,145,812 Nov 12, 2015
Ross Jack President & CEO Purchase 16,522,500 $0.12 $1,982,700 16,522,500 Apr 19, 2015